Metabolic engineering strategies for de novo biosynthesis of sterols and steroids in yeast

Abstract Steroidal compounds are of great interest in the pharmaceutical field, with steroidal drugs as the second largest category of medicine in the world. Advances in synthetic biology and metabolic engineering have enabled de novo biosynthesis of sterols and steroids in yeast, which is a green a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuehao Gu, Xue Jiao, Lidan Ye, Hongwei Yu
Formato: article
Lenguaje:EN
Publicado: SpringerOpen 2021
Materias:
T
Acceso en línea:https://doaj.org/article/dba4a53dfd57415fa9604740d4e524e9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Abstract Steroidal compounds are of great interest in the pharmaceutical field, with steroidal drugs as the second largest category of medicine in the world. Advances in synthetic biology and metabolic engineering have enabled de novo biosynthesis of sterols and steroids in yeast, which is a green and safe production route for these valuable steroidal compounds. In this review, we summarize the metabolic engineering strategies developed and employed for improving the de novo biosynthesis of sterols and steroids in yeast based on the regulation mechanisms, and introduce the recent progresses in de novo synthesis of some typical sterols and steroids in yeast. The remaining challenges and future perspectives are also discussed.